Abstract:Background: The tight coupling between osteoblasts and osteoclasts is essential to maintain bone homeostasis. Deregulation of this process leads to loss and deterioration of the bone tissue causing diseases, such as osteoporosis. MicroRNAs are able to control bone-related mechanisms and have been explored as therapeutic tools. In this study, we investigated the potential of miR-99a-5p to modulate osteogenic differentiation, osteoclastogenesis, and the osteoblasts-osteoclasts crosstalk. Methods: To achieve this goal, human primary Mesenchymal Stem/Stromal Cells (MSC) were differentiated into osteoblasts and adipocytes, and miR-99a-5p expression was evaluated by RT-qPCR. Knockdown and overexpression experiments were conducted to modulate miR-99a-5p expression in MC3T3 cells. Cell proliferation and cell death/apoptosis were evaluated by resazurin assay and flow cytometry, respectively. Proteomic analysis was used to identify the miR-99a-5p regulatory network, and ELISA to evaluate OPG levels in the cell culture supernatant. Conditioned media from MC3T3-transfected cells was used to culture RAW 264.7 cells and the effect on osteoclast differentiation was assessed. Human primary monocytes were isolated to induce osteoclastogenesis and evaluate miR-99a-5p expression. Finally, levels of miR-99a-5p were modulated in RAW 264.7 cells to understand the impact on osteoclastogenesis. Results: The results show that miR-99a-5p is significantly downregulated during the early stages of human primary MSCs osteogenic differentiation and during MC3T3 osteogenic differentiation. On the other hand, miR-99a-5p levels are increased during the initial stages of adipogenic differentiation. Inhibition of miR-99a-5p in MC3T3 pre-osteoblastic cells promoted osteogenic differentiation, whereas its overexpression suppressed the levels of osteogenic specific genes (Runx2 and Alpl), as well as mineralization, with no effect on proliferation or apoptosis. Proteomic analysis of miR-99a-5p-transfected cells showed that numerous proteins known to be involved in cell differentiation were altered, including osteogenic differentiation markers and extracellular matrix proteins. While inhibition of miR-99a-5p increased the Tnfrsf11b (OPG encoding gene)/Tnfsf11 (RANKL encoding gene) mRNA expression ratio, in addition to increasing OPG secretion, miR-99a-5p overexpression resulted in the opposite effect. The cell culture supernatant of miR-99a-5p-inhibited MC3T3 cells impaired the osteoclastogenic potential of RAW 264.7 cells by decreasing the number of multinucleated cells and reducing the expression of osteoclastogenic markers. Interestingly, miR-99a-5p expression is increased during osteoclasts differentiation, both in human primary monocytes and RAW 264.7. These results show that miR-99a-5p per se is a positive regulator of osteoclastogenic differentiation. Conclusions: Globally, our findings show that miR-99a-5p inhibition promotes the commitment into osteogenic differentiation, impairs osteoclastogenic differentiation, and control bone cells communication. Ultimately, it supports miR-99a-5p as a target candidate for future miRNA-based therapies for bone diseases associated with bone remodeling deregulation.

MicroRNA-99a is a novel regulator of KDM6B-mediated osteogenic differentiation of BMSCs

Microrna-98 Regulates Osteogenic Differentiation of Human Bone Mesenchymal Stromal Cells by Targeting Bmp2

miR-99a in bone homeostasis: Regulating osteogenic lineage commitment and osteoclast differentiation

[Effect of MiR-99a-5p on the Differential Ability of Human Bone Marrow Mesenchymal Stem Cells].

Mir-129-5p Promotes Osteogenic Differentiation of BMSCs and Bone Regeneration Via Repressing Dkk3

MicroRNA‑92a Overexpression Promotes the Osteogenic Differentiation of Bone Mesenchymal Stem Cells by Impeding Smad6‑mediated Runt‑related Transcription Factor 2 Degradation

MicroRNA-155 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells Induced by BMP9 Via Downregulation of BMP Signaling Pathway.

Mechanosensitive Mir-99B Mediates the Regulatory Effect of Matrix Stiffness on Bone Marrow Mesenchymal Stem Cell Fate Both in Vitro and in Vivo.

MicroRNA-664a-5p Promotes Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Directly Downregulating HMGA2.

MiR-153-3p Inhibits Osteogenic Differentiation of Periodontal Ligament Stem Cells Through KDM6A-induced Demethylation of H3K27me3.

MicroRNA Regulation in Osteogenic and Adipogenic Differentiation of Bone Mesenchymal Stem Cells and its Application in Bone Regeneration.

Mir-204 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells by Targeting Bone Morphogenetic Protein 2

Exosomes from bone marrow mesenchymal stem cells promoted osteogenic differentiation by delivering miR-196a that targeted Dkk1 to activate Wnt/β-catenin pathway

MicroRNA-378 Promotes Osteogenesis-Angiogenesis Coupling in BMMSCs for Potential Bone Regeneration

TP53-mediated miR-2861 promotes osteogenic differentiation of BMSCs by targeting Smad7

Mirna-20a Promotes Osteogenic Differentiation Of Human Mesenchymal Stem Cells By Co-Regulating Bmp Signaling

miR-126 mitigates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the ERK1/2 and Bcl-2 pathways

MiR-137 Knockdown Promotes the Osteogenic Differentiation of Human Adipose-Derived Stem Cells Via the LSD1/BMP2/SMAD4 Signaling Network.

Inhibition of Microrna-221-5p Induces Osteogenic Differentiation by Directly Targeting Smad3 in Myeloma Bone Disease Mesenchymal Stem Cells

Role of histone methyltransferase KMT2D in BMSC osteogenesis via AKT signaling

MicroRNA-200c promotes osteogenic differentiation of human bone mesenchymal stem cells through activating the AKT/β-Catenin signaling pathway via downregulating Myd88.